The company is now up by 1.28% since yesterday’s close of $192.97. The stock is trading at $195.44 just a bit higher than the 50 day moving average which is $190.53 and which is impressively higher than the 200 day moving average of $178.01. The 50 day moving average went up $5.66 or +2.97% and the 200 day average was up $18.18.
Here is the rundown on market activity for Anthem, Inc. (NYSE:ANTM). Ronald W. Penczek, Sr VP disclosed the sale of 867 shares of (ANTM). The shares were sold on June 7th for an average price of $187.46. The Sr VP now owns $188,397 of the stock according to the SEC filing.
Anthem, Inc., launched on July 17, 2001, is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a full spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations (PPOs); health maintenance organizations (HMOs); point-of-service (POS), plans; indemnity plans and other hybrid plans, including consumer-driven health plans (CDHPs); and hospital only and limited benefit products. In addition, it provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management and analytics-driven personal healthcare. It also provides services to the federal government in connection with the Federal Employee Program (FEP)..
Here are some other firms who have updated their holdings. As of the end of the quarter Piedmont Investment Advisors LLC had bought a total of 1,199 shares growing its position 1.3%. The value in dollars increased from $13,605,000 to $15,849,000 increasing 16.5% since the last quarter. As of quarter end Ballentine Partners, LLC had disposed of 882 shares trimming its holdings by 85.3%. The value of the total investment in Anthem, Inc. went from $130,000 to $25,000 a change of 80.8% quarter to quarter.
As of quarter end Mackenzie Financial Corp had sold a total of 6,176 shares trimming its stake by 16.8%. The value of the investment in Anthem, Inc. decreased from $5,298,000 to $5,073,000 a change of $225,000 quarter over quarter. As of the end of the quarter Stonebridge Capital Advisors LLC had sold 732 shares trimming its position 4.6%. The value of the investment in ANTM went from $2,279,000 to $2,501,000 increasing 9.7% for the reporting period.
August 17 investment analysts at Morgan Stanley kept the stock rating at “Equal-Weight” but raised the price expectation to $201.00 from $196.00. On July 13 Deutsche Bank made no change to the company rating of “Neutral” but moved up the price target from $145.00 to $195.00.
The company recently announced a dividend for shareholders paid on Friday the 23rd of June 2017. The dividend payment was $0.700 per share for the quarter or $2.80 on an annualized basis. The dividend yield was $1.47. The ex-dividend date was set for Wednesday the 7th of June 2017.
The P/E ratio is 18.55 and the market value is 51.52B. As of the latest earnings report the EPS was $10.57 and is projected to be $11.82 for the current year with 262,584,000 shares currently outstanding. Analysts expect next quarter’s EPS to be $1.38 and the next full year EPS is anticipated to be $13.01.